AIS
ICPT

AlphaOne Investment Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

AlphaOne Investment Services’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-145
Closed -$8K – 337
2017
Q3 		$8K Buy
+145
New +$15.6K ﹤0.01% 285

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AlphaOne Investment Services's ICPT Position: Q4 2017 in Review

AlphaOne Investment Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2017, closing a stake of 145 shares — an estimated $8K sold.

AlphaOne Investment Services first reported a position in ICPT in Q3 2017 and held it in 1 quarter. The position peaked at $8K in Q3 2017. 168 funds tracked by Wall St. Rank hold ICPT as of Q4 2017.

  • AlphaOne Investment Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • AlphaOne Investment Services sold 145 Intercept Pharmaceuticals, Inc. shares in Q4 2017, an estimated $8K.
  • AlphaOne Investment Services first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 1 quarter.
  • AlphaOne Investment Services's Intercept Pharmaceuticals, Inc. position peaked at $8K in Q3 2017.
  • 168 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2017.

Based on AlphaOne Investment Services's 13F filing for Q4 2017, filed 12 Feb 2018.